$NPSP NPS PHARMACEUTICALS INC Insider Trading Week 46/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NPS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NPS PHARMACEUTICALS INC in week 46/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Option Exercise | M | 8.25 | 10,782 | 88,952 | 7,188 | |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Option Exercise | M | 3.34 | 31,812 | 106,252 | 20,689 | |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Option Exercise | M | 5.85 | 4,848 | 28,361 | 0 | |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Sell | S | 30.01 | 47,442 | 1,423,640 | 72,780 | 120.2 K to 72.8 K (-39.46 %) |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Buy | M | 8.25 | 10,782 | 88,952 | 120,222 | 109.4 K to 120.2 K (+9.85 %) |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Buy | M | 3.34 | 31,812 | 106,252 | 109,440 | 77.6 K to 109.4 K (+40.98 %) |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | BESHAR LUKE M | EVP & CFO | Buy | M | 5.85 | 4,848 | 28,361 | 77,628 | 72.8 K to 77.6 K (+6.66 %) |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | Rogus Joseph J | SVP, Gbl Technical ... | Option Exercise | M | 3.34 | 26,782 | 89,452 | 85,343 | |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | Rogus Joseph J | SVP, Gbl Technical ... | Sell | S | 30.00 | 26,782 | 803,540 | 20,151 | 46.9 K to 20.2 K (-57.06 %) |
Nov 19 2014 | NPSP | NPS PHARMACEUTICAL ... | Rogus Joseph J | SVP, Gbl Technical ... | Buy | M | 3.34 | 26,782 | 89,452 | 46,933 | 20.2 K to 46.9 K (+132.91 %) |